Dementia disorders refer to a diverse group of conditions characterized by a progressive decrease in cognitive functioning and general mental impairment. The most common types of dementia disorders are Alzheimer's disease, vascular dementia, Lewy Body dementia, frontal temporal dementia, and Parkinson's disease. Alzheimer's disease is believed to be the most common form of dementia. It is characterized by the deterioration of memory, language, motor skills, and the ability to make decisions. It is also characterized by the formation of senile plaques and neurofibrillary tangles in the brain. Vascular dementia is a result of decreased blood flow to the brain due to a stroke or other vascular problem. It is characterized by memory problems, difficulty concentrating, and confusion. Lewy Body dementia is caused by the deposition of abnormal proteins and cellular changes in the brain. It is characterized by fluctuations in alertness, hallucinations, problems with movement, and the inability to perform everyday activities. Frontotemporal dementia is caused by the shrinkage of the temporal and frontal lobes of the brain. It typically affects younger people and is often misdiagnosed as depression or a mental health disorder. Parkinson's disease is also considered to be a type of dementia. It is caused by a loss of dopamine producing neurons in the brain, leading to movement problems such as tremors, speaking difficulties, and difficulty with coordination. Treatment of dementia disorders usually involve medication, therapy, and lifestyle changes. The primary goal of treatment is to provide the patient with support for daily activities and a better quality of life.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom